The Moving Average Convergence Divergence (MACD) for ORMP turned positive on October 27, 2026. Looking at past instances where ORMP's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ORMP's RSI Indicator exited the oversold zone, 20 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
ORMP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORMP as a result. In 75 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
ORMP moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ORMP crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORMP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for ORMP entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 15 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. ORMP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.510) is normal, around the industry mean (2.904). P/E Ratio (0.917) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.257) settles around the average of (128.314) among similar stocks. P/S Ratio (90.909) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ORMP | ||
|---|---|---|
OUTLOOK RATING 1..100 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 15 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 93 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ORMP | |
|---|---|
| RSI ODDS (%) | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 81% |
| Advances ODDS (%) | N/A |
| Declines ODDS (%) | 4 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 83% |
A.I.dvisor tells us that DICE and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DICE and IPSC's prices will move in lockstep.
| Ticker / NAME | Correlation To DICE | 1D Price Change % | ||
|---|---|---|---|---|
| DICE | 100% | +1.62% | ||
| IPSC - DICE | 32% Poorly correlated | +9.87% | ||
| CYTK - DICE | 32% Poorly correlated | +2.07% | ||
| CLDX - DICE | 31% Poorly correlated | +0.74% | ||
| VKTX - DICE | 30% Poorly correlated | +7.21% | ||
| ORMP - DICE | 30% Poorly correlated | +3.25% | ||
More | ||||
A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with DRTS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then DRTS could also see price increases.
| Ticker / NAME | Correlation To ORMP | 1D Price Change % | ||
|---|---|---|---|---|
| ORMP | 100% | +3.25% | ||
| DRTS - ORMP | 52% Loosely correlated | +3.62% | ||
| INO - ORMP | 44% Loosely correlated | -2.41% | ||
| MBIO - ORMP | 44% Loosely correlated | +1.56% | ||
| CGEM - ORMP | 42% Loosely correlated | -20.70% | ||
| CGEN - ORMP | 41% Loosely correlated | +1.00% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDVV | 63.82 | 1.76 | +2.84% |
| Fidelity High Dividend ETF (FDVV) | |||
| ETX | 17.72 | 0.25 | +1.43% |
| EATON VANCE Municipal Income 2028 TERM TRUST | |||
| LONZ | 48.75 | 0.17 | +0.35% |
| PIMCO Senior Loan Active Exchange-Traded Fund (LONZ) | |||
| BFIX | 24.84 | 0.04 | +0.16% |
| Build Bond Innovation ETF (BFIX) | |||
| EHLS | 23.51 | -0.37 | -1.54% |
| Even Herd Long Short ETF (EHLS) | |||